 |
Covance positioned itself as the leading provider of neuroscience antibody products when it acquired key assets of Signet Laboratories, Inc. Signet’s outstanding line of clinical pathology & oncology antibodies, including breast cancer and ovarian cancer markers such as BRST-2, D-240 and HE4.
